Paper41555848
From Clusters to Outcomes: Machine Learning-Based Phenotyping in Intermediate-High-Risk Acute Pulmonary Embolism.
Kultursay B and 19 others. Pulm Circ, 2026. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. From Clusters to Outcomes: Machine Learning-Based Phenotyping in Intermediate-High-Risk Acute Pulmonary Embolism. Papers, record 41555848. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41555848
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- From Clusters to Outcomes: Machine Learning-Based Phenotyping in Intermediate-High-Risk Acute Pulmonary Embolism.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References28
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 40703137 | Clustering of electronic health records in atrial fibrillation patients and impact on prognosis and patient trajectories: a UK linked-dataset study. | Eur Heart J Digit Health | 2025 | https://conductscience.org/library/papers/40703137 | PubMed |
| 2 | 22902901 | Usefulness of cardiac biomarkers in the prediction of right ventricular dysfunction before echocardiography in acute pulmonary embolism. | J Cardiol | 2012 | https://conductscience.org/library/papers/22902901 | PubMed |
| 3 | 37599636 | Current Insights for Catheter-Directed Therapies in Acute Pulmonary Embolism: Systematic Review and Our Single-Center Experience. | Anatol J Cardiol | 2023 | https://conductscience.org/library/papers/37599636 | PubMed |
| 4 | 31504429 | 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). | Eur Heart J | 2020 | https://conductscience.org/library/papers/31504429 | PubMed |
| 5 | 11373204 | New CT index to quantify arterial obstruction in pulmonary embolism: comparison with angiographic index and echocardiography. | AJR Am J Roentgenol | 2001 | https://conductscience.org/library/papers/11373204 | PubMed |
| 6 | 37119189 | A New Index for the Prediction of In-Hospital Mortality in Patients with Acute Pulmonary Embolism: The Modified Shock Index. | Anatol J Cardiol | 2023 | https://conductscience.org/library/papers/37119189 | PubMed |
| 7 | 36736833 | Exploring phenotypes of deep vein thrombosis in relation to clinical outcomes beyond recurrence. | J Thromb Haemost | 2023 | https://conductscience.org/library/papers/36736833 | PubMed |
| 8 | 30082262 | A five-year, single-centre experience on ultrasound-assisted, catheter-directed thrombolysis in patients with pulmonary embolism at high risk and intermediate to high risk. | EuroIntervention | 2018 | https://conductscience.org/library/papers/30082262 | PubMed |
| 9 | 36303697 | Clinical, imaging and hemodynamic correlates and prognostic impact of syncope in acute pulmonary embolism: A single-center study. | Turk Gogus Kalp Damar Cerrahisi Derg | 2022 | https://conductscience.org/library/papers/36303697 | PubMed |
| 10 | 36324223 | An Eight-year, Single-center Experience on Ultrasound Assisted Thrombolysis with Moderate-dose, Slow-infusion Regimen in Pulmonary Embolism. | Curr Vasc Pharmacol | 2022 | https://conductscience.org/library/papers/36324223 | PubMed |
| 11 | 41555848 | From Clusters to Outcomes: Machine Learning-Based Phenotyping in Intermediate-High-Risk Acute Pulmonary Embolism. | Pulm Circ | 2026 | https://conductscience.org/library/papers/41555848 | PubMed |
| 12 | 36112184 | Percutaneous treatment options for acute pulmonary embolism: a clinical consensus statement by the ESC Working Group on Pulmonary Circulation and Right Ventricular Function and the European Association of Percutaneous Cardiovascular Interventions. | EuroIntervention | 2022 | https://conductscience.org/library/papers/36112184 | PubMed |
| 13 | 37477803 | Discovering Distinct Phenotypical Clusters in Heart Failure Across the Ejection Fraction Spectrum: a Systematic Review. | Curr Heart Fail Rep | 2023 | https://conductscience.org/library/papers/37477803 | PubMed |
| 14 | 38706783 | Machine learning analysis of bleeding status in venous thromboembolism patients. | Res Pract Thromb Haemost | 2024 | https://conductscience.org/library/papers/38706783 | PubMed |
| 15 | 34866585 | A seven-year single-center experience on AngioJet rheolytic thrombectomy in patients with pulmonary embolism at high risk and intermediate-high risk. | Anatol J Cardiol | 2021 | https://conductscience.org/library/papers/34866585 | PubMed |
| 16 | 41210338 | From patterns to prognosis: machine learning-derived clusters in advanced heart failure. | Front Cardiovasc Med | 2025 | https://conductscience.org/library/papers/41210338 | PubMed |
| 17 | 38530216 | Is it Time to Reappraise for Black-Box Warning on AngioJet Rheolytic Thrombectomy in Patients with Pulmonary Embolism: A Systematic Review and Meta-analysis. | Anatol J Cardiol | 2024 | https://conductscience.org/library/papers/38530216 | PubMed |
| 18 | 40192167 | Ultrasound-Assisted Catheter-Directed Thrombolytic Therapy Vs. Anticoagulation in Acute Intermediate-High Risk Pulmonary Embolism: A Quasi-Experimental Study. | Anatol J Cardiol | 2025 | https://conductscience.org/library/papers/40192167 | PubMed |
| 19 | 40505225 | Clinical phenotypes and risk of early hemodynamic deterioration in intermediate-high-risk patients with acute pulmonary embolism. | Thromb Res | 2025 | https://conductscience.org/library/papers/40505225 | PubMed |
| 20 | 35975795 | Catheter-directed therapy to treat intermediateand high-risk pulmonary embolism: Personal experience and review of the literature. | Cardiol J | 2023 | https://conductscience.org/library/papers/35975795 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42919191 | Data-driven phenotyping of infective endocarditis using unsupervised machine learning: toward a personalized approach. | BMC Infect Dis | 2026 | https://conductscience.org/library/papers/42919191 | PubMed |
| 42452503 | Interventional Management of Intermediate-High-Risk Pulmonary Embolism: Current Evidence, Patient Selection and Personalised Treatment Strategies. | J Clin Med | 2026 | https://conductscience.org/library/papers/42452503 | PubMed |
| 41555848 | From Clusters to Outcomes: Machine Learning-Based Phenotyping in Intermediate-High-Risk Acute Pulmonary Embolism. | Pulm Circ | 2026 | https://conductscience.org/library/papers/41555848 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CRP | 1401 | PubTator's text mining | https://conductscience.org/library/genes/1401 | NCBI Gene |
| PLAT | 5327 | PubTator's text mining | https://conductscience.org/library/genes/5327 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41555848
GET https://conductscience.org/api/papers/v1/41555848/references?page=2